Ross\Johnson & Associates’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$144 Sell
2
-3
-60% -$231 ﹤0.01% 193
2025
Q4
$397 Buy
5
+3
+150% +$237 0.01% 175
2025
Q3
$151 Hold
2
﹤0.01% 186
2025
Q2
$138 Sell
2
-26
-93% -$1.71K ﹤0.01% 189
2025
Q1
$1.9K Buy
+28
New +$1.68K 0.03% 173

Other funds holding CVS

Ross\Johnson & Associates's CVS Position: Q1 2026 in Review

Ross\Johnson & Associates reduced its CVS Health (CVS) stake by 60% in Q1 2026, selling an estimated $231 and leaving 2 shares worth $144. The position accounts for ﹤0.01% of the portfolio, ranked #193.

Ross\Johnson & Associates first reported a position in CVS in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.9K in Q1 2025. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Ross\Johnson & Associates held 2 shares of CVS Health worth $144 as of Q1 2026.
  • Ross\Johnson & Associates sold 3 CVS Health shares in Q1 2026, an estimated $231.
  • CVS Health made up ﹤0.01% of Ross\Johnson & Associates's portfolio in Q1 2026, its #193 holding.
  • Ross\Johnson & Associates first reported a position in CVS Health in Q1 2025 and has held it in 5 quarters since.
  • Ross\Johnson & Associates's CVS Health position peaked at $1.9K in Q1 2025.
  • 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Ross\Johnson & Associates's 13F filing for Q1 2026, filed 8 May 2026.